After vowing to conduct a full audit on the Democratic national political strategy because of the party’s 2024 election losses, Democratic National Committee Chairman Ken Martin says the findings of ...

Like all other BMW models, the 5-Series is being updated as part of the carmaker’s Neue Klasse era, adopting the new styling of recent concepts and the all-electric iX3. However, it appears BMW is ...

Recursion Pharmaceuticals, Inc. (RXRX) recently received a notable upgrade from JP Morgan analyst Eric Joseph, who shifted his rating to “Overweight” on December 17, 2025. This upgrade comes as the ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recent victories by Democratic gubernatorial candidates in New Jersey and Virginia and for seats on the Georgia Public Service Commission have led outlets like Politico to brand the outcomes as the ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached an initial rampdown phase for bug fixes, with the feature set now frozen. The following 10 features are ...

Perhaps my worst trait is that I’m a Metroidvania purist. It’s annoying, I know, but I’ve always been fascinated with the awkwardly-named subgenre’s little rules and structures. When I play something ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...